Rice, David – Trademark Portfolio
Entity Type: 01
Rice, David holds 12 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 41 (Education & Entertainment) — 7 filings in this category. The portfolio also extends into Class 10 (Medical Apparatus) across 5 Nice Classification classes. Currently, 3 trademarks are registered. Notable registered marks include IGNITEDA, IGNITEDDS, and IS EVERYONE SMILING BUT YOU?. The owner is based in Washington, DC.
300 M Street, SW Suite N110
Washington, DC 20024
Showing of trademarks Trademarks
Trademark Classifications
Rice, David's trademark portfolio spans 5 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Education; providing of training; entertainment; sporting and cultural activities
Advertising; business management; business administration; office functions
Insurance; financial affairs; monetary affairs; real estate affairs
Frequently Asked Questions
How many trademarks does Rice, David have?
Rice, David has 12 U.S. trademarks filed with the USPTO. Of these, 3 registered, 6 abandoned, 3 cancelled.
What trademark classes does Rice, David file in?
Rice, David files trademarks across 5 Nice Classification classes. The most active classes are Class 41 (Education & Entertainment), Class 10 (Medical Apparatus), Class 35 (Advertising & Business), Class 25 (Clothing), Class 36 (Insurance & Financial). Class 41 covers education; providing of training; entertainment; sporting and cultural activities.
What are Rice, David's most well-known trademarks?
Rice, David's registered trademark portfolio includes well-known marks such as IGNITEDA, IGNITEDDS, and IS EVERYONE SMILING BUT YOU?. These are among 3 currently registered trademarks in the portfolio.
What is Rice, David's trademark registration success rate?
Rice, David has a 25% trademark registration rate, with 3 out of 12 resolved applications resulting in successful registration. Currently, 0 applications are pending review.